CDCA4 and hepatocellular carcinoma: These results suggest that there may be an association between CDCA4 and the regulation of immune checkpoints and the sensitivity of certain drugs to hepatocellular carcinoma, providing clues for further investigation of the potential role of CDCA4 in the treatment of hepatocellular carcinoma.